EyePoint, Inc. Increase (Decrease) in Accounts Payable and Accrued Liabilities
EyePoint, Inc. (EYPT) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$525.00 thousand for the 9-month period ending 2012-03-31, per its 10-Q filed 2012-05-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2012-05-10
- EyePoint, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2012-03-31 was $205.00K, a 88.07% increase year-over-year.
- EyePoint, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2011-12-31 was -$357.00K.
- EyePoint, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2011-09-30 was -$373.00K.
- EyePoint, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2011-03-31 was $109.00K.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month |
|---|---|---|---|
| 2012-03-31 | $205.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-10 | -$152.00K derived: sum of 2 quarters · filed 2012-05-10 | -$525.00K 10-Q · filed 2012-05-10 |
| 2011-12-31 | -$357.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2012-02-09 | -$730.00K 10-Q · filed 2012-02-09 | |
| 2011-09-30 | -$373.00K 10-Q/A · filed 2011-11-09 | ||
| 2011-03-31 | $109.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-10 | -$134.00K derived: sum of 2 quarters · filed 2012-05-10 | -$437.00K 10-Q · filed 2012-05-10 |
| 2010-12-31 | -$243.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2012-02-09 | -$546.00K 10-Q · filed 2012-02-09 | |
| 2010-09-30 | -$303.00K 10-Q/A · filed 2011-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |